Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin PK in HSCT
NCT05743400Phase 4Recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2023
- Primary completion
- Apr 2025
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin in graft-versus-host disease (GVHD), sponsored by Hospices Civils de Lyon. Started Sep 2023; status: recruiting.
02
Drugs
antithymocyte globulin
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT05743400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05743400.